Appearance:clear colorless liquid or low melting solid
Purity:99%
Chemical Properties
2-Pyrrolidinone occurs as a colorless or slightly grayish liquid, as white or almost white crystals, or colorless crystal needles. It has a characteristic odor. miscible with water, alcohol, ether, chloroform, benzene, ethyl acetate and carbon disulfide, insoluble in petroleum ether.
Uses
2-Pyrrolidinone is a widely used organic polar solvent for various applications. 2-Pyrrolidinone is also an intermediate in the manufacture of polymers.
Uses
2-pyrrolidone widely exists in various physiologically active natural products in nature. For example, it is the main structural unit of gonadotropin releasing hormone. At the same time, 2-pyrrolidone is an important raw material and intermediate of medicine, pesticide, dye, peptide and other chemicals. If it is used as the end chain of peptide, it also plays a stable role in the conformation of the compound. Many polysubstituted 2-pyrrolidones have been used in the synthesis and production of a variety of drugs and applied for patents.
Preparation
Pyrrolidone is prepared from butyrolactone by a Reppe process, in which acetylene is reacted with formaldehyde.
Definition
ChEBI: 2-Pyrrolidinone is the simplest member of the class of pyrrolidin-2-ones, consisting of pyrrolidine in which the hydrogens at position 2 are replaced by an oxo group. The lactam arising by the formal intramolecular condensation of the amino and carboxy groups of gamma-aminobutyric acid (GABA). It has a role as a polar solvent and a metabolite.
Production Methods
The synthesis of 2-pyrrolidone was first reported in 1889 as the product of dehydration of 4-aminobutanoic acid. It is produced commercially by condensation of butyrolactone with ammonia, a method first described in 1936. Other synthetic routes include carbon monoxide insertion into allylamine, hydrolytic hydrogenation of succinonitrile, and hydrogenation of ammoniacal solutions of maleic and succinnic acids (Hort and Anderson 1978).
Reactions
2-Pyrrolidone undergoes the reactions of a typical lactam, e.g. ring opening, attack on the carbonyl group, and replacement of hydrogens alpha to the carbonyl group. Strong acids and bases catalyze the hydrolysis of 2-pyrrolidone to 4-aminobutanoic acid (GABA). The hydrogen atom on the nitrogen atom is easily replaced by alkylation reactions with alkyl halide or sulfates, or reaction with acid anhydrides, acyl halides, ethylene oxide, and styrene. Condensation reactions with secondary amines and alcohols, and O-alkylation reactions occur at the carbonyl group. In the presence of anionic catalyst systems, 2-pyrrolidone is polymerized to polypyrrolidone, nylon-4 (Hort and Anderson 1978).
Health Hazard
Exposure to 2-pyrrolidone produces irritation to the eyes, mucous membranes, and skin. Although reported to be a skin sensitizer in animal tests, there is no indication that 2-pyrrolidone is a skin sensitizer in human exposures (Anon 1975). 2-Pyrrolidone has been reported to enhance the permeability of human skin for methanol, but reduced the permeability for octanol (Southwell et al 1983).
Flammability and Explosibility
Nonflammable
Pharmaceutical Applications
Pyrrolidone and N-methylpyrrolidone are mainly used as solvents in veterinary injections. Pyrrolidone has been shown to be a better solubilizer than glycerin, propylene glycol, or ethanol. They have also been suggested for use in human pharmaceutical formulations as solvents in parenteral, oral, and topical applications. In topical applications, pyrrolidones appear to be effective penetration enhancers. Pyrrolidones have also been investigated for their application in controlled-release depot formulations.
Industrial uses
2-Pyrrolidone is used as an intermediate for synthesis of l-vinyl-2-pyrrolidone and various TV-methylol derivatives used as textile-finishing agents; as a solvent for various polymers, chlordane and DDT, d-sorbitol, glycerin, and sugars; and as a decolorizing agent for kerosene, fatty oils, and rosins. N-methyl-2-pyrrolidone and 2-pyrrolidone are utilized in petroleum refining to selectively extract aromatics from paraffinic hydrocarbons. 2-Pyrrolidone is used as a plasticizer and coalescing agent for acrylic latices and acrylic/styrene copolymers in emulsion coatings, i.e. floor waxes. A linear high molecular weight polyamide polymer of 2-pyrrolidone, nylon-4, is used as a textile fiber, injection molding compound, and film-forming polymer (Anon. 1975; Hort and Anderson 1978).
Safety
Pyrrolidones are mainly used in veterinary injections and have also been suggested for use in human oral, topical, and parenteral pharmaceutical formulations. In mammalian species, pyrrolidones are biotransformed to polar metabolites that are excreted via the urine. Pyrrolidone is mildly toxic by ingestion and subcutaneous routes; mutagenicity data have been reported. LD50 (guinea pig, oral): 6.5 g/kg LD50 (rat, oral): 6.5 g/kg
Metabolism
A metabolite of 2-pyrrolidone, 4-aminobutanoic acid has been identified in animals (Lundgren et al 1980). 2-Pyrrolidone has been reported to be an endogenous constituent in the brains of mice (Callery et al 1978) and bovine (Mori et al 1975). The aliphatic polyamine putrescine has been demonstrated to be metabolized to 2-pyrrolidone in rat liver slices (Lundgren and Hankins 1978; Lundgren et al 1985) and to lesser extent by slices of spleen and lung, but not in tissue slices from kidney, brain, heart, or rear leg muscle (Lundgren and Hankins 1978). The metabolism of putrescine is catalyzed by the microsomal enzyme diamine oxidase (EC 1.4.3.6) to 4-aminobutyraldehyde, which is subsequently oxidized to the neurotransmitter 4-aminobutanoic acid (4-aminobutyric acid, GAB A) or is cyclized to delta1-pyrroline (Seiler 1980; Lundgren et al 1980; Callery et al 1980), which is in turn oxidized to 5-hydroxy-2-pyrrolidone (Lundgren and Fales 1980). There is evidence that 5-hydroxy-2-pyrrolidone is further metabolized to succinimide, malimide, 2- and 3-hydroxysuccinamic acids, maleamic acid, and carbon dioxide (Bandle et al 1984). An enzyme system residing in the soluble fraction of rabbit liver catalyzes the conversion of delta'-pyrroline to ?-aminobutyric acid and its lactam, 2-pyrrolidone (Callery et al 1982). 2-Pyrrolidone has been identified as a urinary metabolite of N-nitrosopyrrolidine (Cottrell et al 1980) and the drug methadone (Kreek 1980).
storage
Pyrrolidone is chemically stable and, if it is kept in unopened original containers, the shelf-life is approximately one year. Pyrrolidone should be stored in a well-closed container protected from light and oxidation, at temperatures below 20°C.
Incompatibilities
Pyrrolidone is incompatible with oxidizing agents and strong acids.
InChI:InChI=1/C4H7NO/c6-4-2-1-3-5-4/h1-3H2,(H,5,6)
Oxidation of cis or trans 1,5-diazadecalin with (PhIO)n yields 2-pyrrolidinone and not 1,6-diaza-2,7-cyclodecadione, as reported. This is shown by a comparison of the NMR data of the reaction product with those of 2-pyrrolidinone and 1,6-diaza-2,7-cyclodecadione.
Atomically precise gold cluster catalysts have emerged as a new frontier in catalysis science, owing to their unexpected catalytic properties. In this work, we explore the evolution of the catalytic activity of clusters formed by the structural fusion of icosahedral Au13 units, namely Au25(SR)18, Au38(SR)24, and Au25(PPh3)10(SC2H4Ph)5Cl2, in the oxidation of pyrrolidine to γ-butyrolactam. We demonstrate that the structural fusion of icosahedral Au13 units, forming vertex-fused (vf), face-fused (ff), and body-fused (bf) clusters, can induce a decrease in the catalytic activity in the following order: Aubf > Auff > Auvf. The structural fusion of icosahedral Au13 units in the clusters does not distinguish the adsorption modes of pyrrolidine over the three clusters from each other, but modulates the chemical adsorption capacity and electronic properties of the three clusters, which is likely to be the key reason for the observed changes in catalytic reactivity. Our results are expected to be extendable to study and design atomically defined catalysts with elaborate structural patterns, in order to produce desired products.
-
-
Glutamic acid, an abundant nonessential amino acid, was converted into 2-pyrrolidone in the presence of a supported Ru catalyst under a pressurized hydrogen atmosphere. This reaction pathway proceeded through the dehydration of glutamic acid into pyroglutamic acid, subsequent hydrogenation, and the dehydrogenation–decarbonylation of pyroglutaminol into 2-pyrrolidone. In the conversion of pyroglutaminol, Ru/Al2O3 exhibited notably higher activity than supported Pt, Pd, and Rh catalysts. IR analysis revealed that Ru can hydrogenate the formed CO through dehydrogenation–decarbonylation of hydroxymethyl groups in pyroglutaminol and can also easily desorb CH4 from the active sites on Ru. Furthermore, Ru/Al2O3 showed the highest catalytic activity among the tested catalysts in the conversion of pyroglutamic acid. Consequently, the conversion of glutamic acid produced a high yield of 2-pyrrolidone by using the supported Ru catalyst. This is the first report of this one-pot reaction under mild reaction conditions (433 K, 2 MPa H2)? which avoids the degradation of unstable amino acids above 473 K.
-
Herein, we report the isolation and a reactivity study of the first example of an elusive palladium(II) terminal imido complex. This scaffold is an alleged key intermediate for various catalytic processes, including the amination of C?H bonds. We demonstrate facile nitrene transfer with H?H, C?H, N?H, and O?H bonds and elucidate its role in catalysis. The high reactivity is due to the population of the antibonding highest occupied molecular orbital (HOMO), which results in unique charge separation within the closed-shell imido functionality. Hence, N atom transfer is not necessarily associated with the high valency of the metal (PdIII, PdIV) or the open-shell character of a nitrene as commonly inferred.
We have synthesized compounds: N-(2-aminoacetyl)-2-pyrrolidone (1) and N-(2-aminoacetyl)-2-piperidone (2). When these compounds are dissolved in aprotic or protic solvents a fast equilibrium ca. 1:1 between the cyclol form (tetrahedral intermediate) and the bislactam macrocycle is established. The same result has been reported previously for N-(2-aminoacetyl)-2-caprolactam (3). For compounds 2 and 3, dynamic 1H-NMR (using the methylene signals α to the carbonyl and to the amino group) through spectrum simulation has been used to evaluate the exchange between the two mentioned forms at different pH. However, for compound 1 the exchange was evaluated using magnetization transfer technique. The more stable bislactam configuration of the macrocycle form in compounds 2 and 3, is the trans-cis (one lactam with the cyclic alkyl chains trans oriented and the other cis oriented). However, the same form for compound 1 has a more stable cis-cis bislactam configuration. This difference in configuration induces substantial changes in the appearance of the methylene 1H-NMR signals that precludes the use of line-shape analysis to evaluate the rates. The rate law for the proposed mechanism of exchange between the cyclol form and the macrocycle is: K = [macrocycle]/[cyclol] =kobs.f/kobs.r = Kak2[H2O]/[H+]/k-2Kw /[H+] = Kak2[H2O]/k-2Kw; where Ka is the acidity equilibrium constant of the cyclol form, Kw = 10-14 M2 and k2 and k-2 are the second order rate constants for the specific exchange catalysis. Therefore, both, the macrocycle formation (kobs.f) and the cyclol formation (kobs.r) are specific base catalyzed; however the equilibrium constant is independent of pH. Since K is ca. 1, the δG≠ associated with the measured rate constants represent the intrinsic barrier for this non-identical thermoneutral transformation where a cleavage of a tetrahedral intermediate is involved. The activation energies associated with the reverse rate constants then correspond to the intrinsic barrier for transannular cyclolization.
Kinetics of formation of thermolysis products in heating of thin films of poly-N-vinylpyrrolidone and of poly-N-vinylpyrrolidone with covalently bound fullerene C60 was studied by thermal desorption mass spectrometry.
The catalytic aerobic α-oxidation of amines in water is an atom economic and green alternative to current methods of amide synthesis. The reaction uses O2 as terminal oxidant, avoids hazardous reactants and gives water as the only byproduct. Here we report that the catalytic activity of silica-supported Au nanoparticles for the aerobic α-oxidation of amines can be improved by tethering pyridyl ligands to the support. In contrast, immobilization of thiol groups on the material gives activities comparable to Au supported on bare silica. Our studies indicate that the ligands affect the electronic properties of the Au nanoparticles and thereby determine their ability to activate O2 and mediate C-H cleavage in the amine substrate. The reaction likely proceeds via an Au catalyzed β-hydride elimination enabled by backdonation from electron-rich metal to the orbital. O2, which is also activated on electron-rich Au, acts as a scavenger to remove H from the metal surface and regenerate the active sites. The mechanistic understanding of the catalytic conversion led to a new approach for forming C-C bonds α to the N atoms of amines.
The present disclosure provides compounds and methods useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration.
Lactams are cyclic amides that are indispensable as drugs and as drug candidates. Conventional lactamization includes acid-mediated and coupling-agent-mediated approaches that suffer from narrow substrate scope, much waste, and/or high cost. Inexpensive, less-wasteful approaches mediated by highly electrophilic reagents are attractive, but there is an imminent risk of side reactions. Herein, a methods using highly electrophilic triphosgene in a microflow reactor that accomplishes rapid (0.5–10 s), mild, inexpensive, and less-wasteful lactamization are described. Methods A and B, which use N-methylmorpholine and N-methylimidazole, respectively, were developed. Various lactams and a cyclic peptide containing acid- and/or heat-labile functional groups were synthesized in good to high yields without the need for tedious purification. Undesired reactions were successfully suppressed, and the risk of handling triphosgene was minimized by the use of microflow technology.
carbon monoxide
1-amino-2-propene
2-pyrrolidinon
1,3-diallylurea
| Conditions | Yield |
|---|---|
|
With tributylphosphine; cobalt(II) acetate; In methanol; at 25 ℃; Irradiation;
|
1.8 % Chromat. 20.4 % Chromat. |
carbon monoxide
1-amino-2-propene
2-pyrrolidinon
1,3-diallylurea
N-allyl-3-butenamide
| Conditions | Yield |
|---|---|
|
dicobalt octacarbonyl; In methanol; at 25 ℃; for 18h; Product distribution; Irradiation; other catalyst, other solvents, other gas, other substrates;
|
2.1 % Chromat. 13.0 % Chromat. 3.8 % Chromat. |
|
With hydrogen; dicobalt octacarbonyl; In methanol; at 25 ℃; for 18h; Irradiation;
|
2.6 % Chromat. 13.3 % Chromat. 6.0 % Chromat. |
|
dicobalt octacarbonyl; In benzene; at 25 ℃; for 42h; Irradiation;
|
10.7 % Chromat. 4.8 % Chromat. 17.2 % Chromat. |
4-butanolide
Succinimide
glutaric anhydride,
γ-chlorobutyric acid
1-(2-hydroxyethyl)-2-pyrrolidinone
4-(2,5-dioxopyrrolidin-1-yl)butanoic acid
N-(2-hydroxy-2-phenylethyl)pyrrodidin-2-one
1-methyl-pyrrolidin-2-one
